3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
sodium thiosulfate
2
cabozantinib
1
Restraint, Physical
1
Ramucirumab
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Liver Neoplasms
×
Ramucirumab
×
Clear all
NCT02435433
2023-01-20
REACH-2
Eli Lilly and Company
Phase 3
Completed
399 enrolled
22 charts
1 FDA